Apium graveolens Prevents Intrauterine Growth Restriction via Suppression of Antiangiogenic Factor Production

Hikmah, Exma Mu'tatal; Liben, Paulus; Widjiati, Widjiati

doi:10.22146/mot.36112

Cited by 1 publication

(1 citation statement)

References 26 publications

(34 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previously, Manolescu [145] has observed that apigenin exhibited an endothelial nitric oxide synthase (eNOS) stimulation effect and was able to inhibit HIF-1 α expression as a factor causing placental hypoxia by blocking its interactions with HIF-1 α -Hsp90 receptors. Recently, Hikmah et al [146] have shown that an extract from Apium graveolens containing apigenin can prevent intrauterine growth restriction via suppression of antiangiogenic factors production in PIH animal model because it inhibited action of TNF α and HIF-1 α .…”

Section: Other Natural Compounds Testedmentioning

confidence: 99%

Pharmacological Effect of Quercetin in Hypertension and Its Potential Application in Pregnancy‐Induced Hypertension: Review of In Vitro, In Vivo, and Clinical Studies

Ożarowski

Mikołajczak

Kujawski

et al. 2018

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

Since improving maternal and child health is a public health priority worldwide, the main aim of treatment of hypertension in pregnant women is to prevent complications during pregnancy, labor, and postpartum. In consequence, much attention is paid to the use of antihypertensive drugs that can be used safely during pregnancy. Several side effects of methyldopa, which is currently the most commonly used antihypertensive drug in pregnant women, mean that the search for an effective and safe alternative still continues. Flavonoid compounds present in medicinal plants, vegetables, and fruits may be a promising source of new drugs. In this aspect, quercetin, a well-known flavonoid due to its antihypertensive action, may be considered a prototype for safe antihypertensive drugs. This review focuses on the selective activity of quercetin. Based on recent studies, a few problems were discussed, including (1) pathology of pregnancy-induced hypertension; (2) search for new pharmacological treatments of pregnancy-induced hypertension; (3) issues with the use of herbal extracts during pregnancy; (4) flavonoids as natural active chemical compounds; (5) quercetin: its action during pregnancy, in vitro and in vivo pharmacological activities, clinical trials, and meta-analysis; (6) quercetin intake during pregnancy; (7) other natural compounds tested during pregnancy; (8) potential problems with the use of quercetin; (9) safety profile of quercetin. Various studies have shown a beneficial effect of quercetin on vascular endothelial function and its antioxidative and anti-inflammatory activity on cellular and tissue level. It is known that in animal models quercetin affects positively the development of embryo, fetus, and placenta. Because this flavonoid did not have teratogenic and abortive effect, it is generally recognized as safe. For this reason it should be appreciated and studied in the aspect of its potential use in the prevention and treatment of pregnancy-induced hypertension among women in this risk group.

show abstract

Section: Other Natural Compounds Testedmentioning

confidence: 99%